Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $316.0100 (0.56%) ($313.8050 - $318.4800) on Mon. Apr. 23, 2018. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.18% (three month average) | | RSI | 37 | | Latest Price | $316.0100(0.56%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | | Weekly Trend | REGN declines -1.5% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(50%) IVW(43%) XBI(43%) IWF(42%) | | Factors Impacting REGN price | REGN will decline at least -1.09% in a week (0% probabilities).
UUP(-10%) TLT(-6%) VIXM(-5%) DRIV(-4%) DIA(-2%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.09% (StdDev 2.18%) | | Hourly BBV | 0 () | | Intraday Trend | -0% | | | | | |
|
| Resistance Level | $325.42 | | 5 Day Moving Average | $318.02(-0.63%) | | 10 Day Moving Average | $320.35(-1.35%) | | 20 Day Moving Average | $325.42(-2.89%) | | To recent high | -19.4% | | To recent low | 0.6% | | Market Cap | $33.506b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |